Skip to Content
UW Health SMPH
American Family Children's Hospital
E. Jason Abel, MD close
E. Jason Abel, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

E. Jason Abel, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Abel is board certified by the American Board of Urology and specializes in the surgical treatment of urologic malignancies. He has advanced training to surgically manage all types of genitourinary cancers, including prostate cancer, bladder cancer, kidney cancer, testis cancer and penile cancer.


Dr. Abel performs open and laparoscopic surgery, including surgery using the daVinci robot. His philosophy is to provide maximal quality of life to patients by using minimally invasive approaches to cancer therapy whenever appropriate. He has a special interest in the treatment of localized and locally advanced kidney cancer.



UW Health Clinics

University Hospital
(608) 263-4757 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)
Meriter Hospital, Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Urology

Professional Certifications and Education

Board Certification Urology

Urologic Oncology, M.D. Anderson Cancer Center, Houston, TX

Residency University of Utah, Salt Lake City, UT, UT
Internship University of Utah, Salt Lake City, UT, UT
Medical School University of Texas Medical School, Houston, TX, 2003

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.


Dr. Abel conducts clinical, translational and basic research in urologic oncology. He currently is involved in several projects focusing on the development and metastasis of kidney cancer.

PubMed Articles
Blute ML Zorn K Grimes M Shi F Downs TM Jarrard DF Best SL Richards K Nakada SY Abel EJ . Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer. BJU Int. 2015 Nov 21;
[PubMed ID: 26589741]
Blute ML Jr Rushmer TJ Shi F Fuller BJ Abel EJ Jarrard DF Downs TM . Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer. J Urol. 2015 Nov;194(5):1214-9
[PubMed ID: 26173101]
Abel EJ Heckman JE Hinshaw L Best S Lubner M Jarrard DF Downs TM Nakada SY Lee FT Jr Huang W Ziemlewicz T . Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses. J Urol. 2015 Oct;194(4):886-91
[PubMed ID: 25837535]
Cristescu M Abel EJ Wells S Ziemlewicz TJ Hedican SP Lubner MG Hinshaw JL Brace CL Lee FT Jr . Percutaneous Microwave Ablation of Renal Angiomyolipomas. Cardiovasc Intervent Radiol. 2015 Sep 21;
[PubMed ID: 26390876]
Abel EJ Margulis V Bauman TM Karam JA Christensen WP Krabbe LM Haddad A Golla V Wood CG . Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis. BJU Int. 2015 Aug 25;
[PubMed ID: 26305276]
Blute ML Jr Abel EJ Downs TM Kelcz F Jarrard DF . Addressing the need for repeat prostate biopsy: new technology and approaches. Nat Rev Urol. 2015 Aug;12(8):435-44
[PubMed ID: 26171803]
Potretzke AM Wong KS Shi F Christensen W Downs TM Abel EJ . Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers. Urol Ann. 2015 Jul-Sep;7(3):355-60
[PubMed ID: 26229325]
Karam JA Devine CE Fellman BM Urbauer DL Abel EJ Allaf ME Bex A Lane BR Thompson RH Wood CG . Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial. BJU Int. 2015 Jun 1;
[PubMed ID: 26033220]
Prince J Bultman E Hinshaw L Drewry A Blute M Best S Lee FT Jr Ziemlewicz T Lubner M Shi F Nakada SY Abel EJ . Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol. 2015 Jun;193(6):1899-904
[PubMed ID: 25498574]
Abel EJ Linder BJ Bauman TM Bauer RM Thompson RH Thapa P Devon ON Tarrell RF Frank I Jarrard DF Downs TM Boorjian SA . Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol. 2014 Dec;66(6):1139-47
[PubMed ID: 25194909]
Abel EJ Carrasco A Karam J Tamboli P Delacroix S Vaporciyan AA Wood CG . Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus. BJU Int. 2014 Nov;114(5):667-73
[PubMed ID: 24128265]
Haddad AQ Wood CG Abel EJ Krabbe LM Darwish OM Thompson RH Heckman JE Merril MM Gayed BA Sagalowsky AI Boorjian SA Margulis V Leibovich BC . Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J Urol. 2014 Oct;192(4):1050-6
[PubMed ID: 24704115]
Abel EJ Thompson RH Margulis V Heckman JE Merril MM Darwish OM Krabbe LM Boorjian SA Leibovich BC Wood CG . Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. 2014 Sep;66(3):584-92
[PubMed ID: 24262104]
Moreland AJ Ziemlewicz TJ Best SL Hinshaw JL Lubner MG Alexander ML Brace CL Kitchin DR Hedican SP Nakada SY Lee FT Jr Abel EJ . High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation. J Endourol. 2014 Sep;28(9):1046-52
[PubMed ID: 24846329]
Abel EJ Bauman TM Weiker M Shi F Downs TM Jarrard DF Huang W . Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. Hum Pathol. 2014 May;45(5):1092-9
[PubMed ID: 24746216]
Abel EJ Wong K Sado M Leverson GE Patel SR Downs TM Jarrard DF . Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS. 2014 Apr-Jun;18(2):282-7
[PubMed ID: 24960494]
Truong M Slezak JA Lin CP Iremashvili V Sado M Razmaria AA Leverson G Soloway MS Eggener SE Abel EJ Downs TM Jarrard DF . Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer. 2013 Nov 15;119(22):3992-4002
[PubMed ID: 24006289]
Abel EJ Fisher MB Matin SF Kamat AM Dinney CP Grossman HB . Delayed ureterectomy after incomplete nephroureterectomy for upper tract urothelial carcinoma: pathologic findings and outcomes. Int Braz J Urol. 2013 Nov-Dec;39(6):817-22
[PubMed ID: 24456786]
Abel EJ Wood CG Eickstaedt N Fang JE Kenney P Bagrodia A Youssef RF Sagalowsky AI Margulis V . Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol. 2013 Aug;190(2):452-7
[PubMed ID: 23434945]
Margulis V Shariat SF Rapoport Y Rink M Sjoberg DD Tannir NM Abel EJ Culp SH Tamboli P Wood CG . Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol. 2013 May;63(5):947-52
[PubMed ID: 23273681]